Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage, and antioxidant activity of 1, 10-phenanthroline ruthenium(II) complexes

DNA and Cell Biology

Volumn 30, Issue 10, 2011, Pages 839-848

  Liu, Yun Jun ^a   Li, Zheng Zheng ^a   Liang, Zhen Hua ^a   Yao, Jun Hua ^b   Huang, Hong Liang ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACRIDINE ORANGE; ETHIDIUM BROMIDE; INTERCALATING AGENT; RUTHENIUM DERIVATIVE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA CLEAVAGE; DNA DENATURATION; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY; VISCOMETRY;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; HYDROXYL RADICAL; INTERCALATING AGENTS; KINETICS; LIVER NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; PHENANTHROLINES; PHOTOLYSIS; PLASMIDS; RUTHENIUM; SPECTRUM ANALYSIS; ULTRAVIOLET RAYS;

EID: 80053506428     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1243     Document Type: Article

References (41)

1. Ang, W.H., and Dyson, P.J. (2006). Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Eur J Inorg Chem 20, 4003-4018.
2. Anthonysamy, A., Balasubramanian, S., Shanmugaiah, V., and Mathivanan, N. (2008). Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation. Dalton Trans 16, 2136-2143.
3. Arockiasamy, D.L., Radhika, S., Parthasarathi, R., and Nair, B.N. (2009). Synthesis and DNA-binding studies of two ruthenium( II) complexes of anintercalating ligand. Eur J Med Chem 44, 2044-2051.
4. Carter, M.T., Rodriguez, M., and Bard, A. (1989). Voltammetric studies of the interaction of metal chelates with DNA. 2. Trischelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine. J Am Chem Soc 111, 8901-8911. (Pubitemid 20050086)
5. Chaires, J.B., Dattagupta, N., and Crothers, D.M. (1982). Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid. Biochemistry 21, 3933-3940. (Pubitemid 13237187)
6. Chen, T., and Wong, Y.S. (2008a). Selenocystine induces apoptosis of A375 human melanoma cells by activating ROSmediated mitochondrial pathway and p53 phosphorylation. Cell Mol Life Sci 65, 2763-2775.
7. Chen, T., and Wong, Y.S. (2008b). Selenocystine induces s-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation. J Agric Food Chem 56, 10574-10581.
8. Chen, T.F., Liu, Y.N., Zheng, W.J., Liu, J., and Wong, Y.S. (2010). Ruthenium polypyridyl complexes that induce mitochondriamediated apoptosis in cancer cells. Inorg Chem 49, 6366-6368.
9. Cheng, C.C., Rokita, S.E., Burrows, C.J., and Burrows, C.J. (1993). Nickel(III)-promoted DNA cleavage with ambient dioxygen. Angew Chem Int Ed Engl 32, 277-278.
10. Cocchietto, M., and Sava, G. (2000). Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol 87, 193-197.
11. Cohen, G., and Eisenberg, H. (1969). Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 8, 45-55.
12. Du, K.J., Wang, J.Q., Kou, J.F., Li, G.Y., Wang, L.L., Chao, H., and Ji, L.N. (2011). Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes. Eur J Med Chem doi:10.1016/j.ejmech.2011. 01.019.
13. Hartinger, C.G., Jakupec, M.A., Zorbas-Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P.J., and Keppler, B.K. (2008). KP1019, a new redox-active anticancer agent- preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers 5, 2140-2155.
14. Hartinger, C.G., Zorbas-Seifried, S., Jakupec, M.A., Kynast, B., Zorbas, H., and Kepper, B.K. (2006). Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. J Inorg Biochem 100, 891-904.
15. Huang, H.L., Liu, Y.J., Zeng, C.H., He, L.X., and Wu, F.H. (2010). In vitro cytotoxicity, apoptosis, DNA-Binding, and antioxidant activity studies of ruthenium (II) complexes. DNA Cell Biol 29, 261-270.
16. Jamicson, E.R., and Lippard, S.J. (1999). Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99, 2467-2498.
17. Liu, H.Q., Tzeng, B.C., You, Y.S., Peng, S.M., Chen, H.L., Yang, M.S., and Che, C.M. (2002). Syntheses of ruthenium(II) quinonediimine complexes of cyclam and characterization of their DNA-binding activities and cytotoxicity. Inorg Chem 41, 3161-3171.
18. Liu, Y.J., Liang, Z.H., Li, Z.Z., Zeng, C.H., Yao, J.H., Huang, H.L., and Wu, F.H. (2010a). 2-(3,5-Dibromo-4-hydroxyphenyl) imidazo[4,5-f][1,10] phenanthrolinoruthenium (II) complexes:synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity. BioMetals 23, 739-752.
19. Liu, Y.J., Zeng, C.H., Huang, H.L., He, L.X., and Wu, F.H. (2010b). Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes. Eur J Med Chem 45, 564-571.
20. Liu, Y.J., Zeng, C.H., Liang, Z.H., Yao, J.H., Huang, H.L., Li, Z.Z., and Wu, F.H. (2010c). Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity. Eur J Med Chem 45, 3087-3095.
21. Liu, Y.J., Zeng, C.H., Yao, J.H., Wu, F.H., He, L.X., and Huang, H.L. (2010d). Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium (II) polypyridyl complexes. Chem Biodivers 7, 1770-1783.
22. Lo, K.K., Lee, T.K., Lau, J.S., Poon, W.L., and Cheng, S.H. (2008). Luminescent biological probes derived from ruthenium( II) estradiol polypyridine complexes. Inorg Chem 47, 200-208.
23. Marmur, J. (1961). A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3, 208-218.
24. McGhee, J.D. (1976). Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands. Biopolymers 15, 1345-1375.
25. Mosmann, T. (1983). Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors. J Immunol Methods 65, 55-63.
26. Neyhart, G.A., Grover, N., Smith, S.R., Kalsbeck, W.A., Fairley, T.A., Cory, M., and Thorp, H.H. (1993). Binding and kinetics studies of oxidation of DNA by oxoruthenium(IV). J Am Chem Soc 115, 4423-4428.
27. Reichmann, M.E., Rice, S.A., Thomas, C.A., and Doty, P. (1954). A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76, 3047-3053.
28. Rosenberg, B., Van Camp, L., Trosko, J.E., and Mansour, V.H. (1969). Platinum compounds: a new class of potent antitumour agents. Nature 222, 385-386.
29. Sathyaraj, G., Weyhermü ller, T., and Nair, B.N. (2010). Synthesis, characterization and DNA binding studies of new ruthenium( II)bisterpyridine complexes. Eur J Med Chem 45, 284-291.
30. Satyanarayana, S., Dabrowial, J.C., and Chaires, J.B. (1992). Neither .DELTA (D).- nor .LAMBDA (L).-tris(phenanthroline) ruthenium(II) binds to DNA by classical intercalation. Biochemistry 31, 9319-9324.
31. Satyanarayana, S., Dabrowiak, J.C., and Chaires, J.B. (1993). Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 32, 2573-2584. (Pubitemid 23090644)
32. Schatzschneider, U., Niesel, J., Ott, I., Gust, R., Alborzinia, H., and Wö lfl, S. (2008). Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium( II) polypyridyl complexes [Ru(bpy)2(N-N)]Cl2 with N-Nbpy, phen, dpq, dppz, and dppn. ChemMedChem 3, 1104-1109.
33. Spector, D.L., Goldman, R.D., and Leinwand, L.A. (1998). Cells: A Laboratory Manual Vol. 1, Chapter 15. (Cold Spring Harbor Laboratory Press, New York).
34. Steck, E.A., and Day, A.R. (1943). Reactions of phenanthraquinone and retenequinone with aldehydes and ammonium acetate in acetic acid solution. J Am Chem Soc 65, 452-456.
35. Sullivan, B.P., Salmon, D.J., and Meyer, T.J. (1978). Mixed phosphine 2,2'-bipyridine complexes of ruthenium. Inorg Chem 17, 3334-3341.
36. Tan, L.F., Shen, J.L., Chen, X.J., and Liang, X.L. (2009). In vitro study of DNA binding of ruthenium complexes with polypyridyl ligands. DNA Cell Biol 28, 461-468.
37. Waring, M.J. (1965). Complex formation between ethidium bromide and nucleic acids. J Mol Biol 13, 269-274.
38. Wong, E., and Giandomenico, C.M. (1999). Current status of platin-based antitumor drugs. Chem Rev 99, 2451-2466.
39. Yamada, M., Tanaka, Y., Yoshimoto, Y., Kuroda, S., and Shimao, I. (1992). Synthesis and properties of diamino-substituted dipyrido [3,2-a: 20,30-c]phenazine. Bull Chem Soc Jpn 65, 1006-1011.
40. Yan, Y.K., Melchart, M., Habtemariam, A., and Sadler, P.J. (2005). Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun 38, 4764-4776. (Pubitemid 41509143)
41. Zorzet, S., Sorce, A., Casarsa, C., Cocchietto, M., and Sava, G. (2001). Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. Met Based Drugs 8, 1-7. (Pubitemid 32674265)